CompletedPhase 4NCT03344159
Spironolactone Therapy in Chronic Stable Right HF Trial
Studying Dextrocardia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ottawa Heart Institute Research Corporation
- Principal Investigator
- Lisa Mielniczuk, MDOttawa Heart Institute Research Corporation
- Intervention
- Spironolactone(drug)
- Enrollment
- 15 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2024
Study locations (1)
- University of Ottawa Heart Institute, Ottawa, Ontario, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03344159 on ClinicalTrials.gov